Skip to main content
Research Grant
Loading...
  • Home
  • Getting Started
  • FAQ
  • My Grant Requests
  • About Us
    About Edwards Contact Us
  • Global Grant Home
    • ☰
    Edwards
    account_circle
    Content Starts Here
    Educational Grant (CME) In-Kind Educational Grant Request (product only) Fellowship Funding Charitable Donation Sponsorship (non-CME)

    Back to homeEducational Mission Statement

    Edwards Lifesciences is committed to supporting educational conferences, symposia, trainings and programs in order to support knowledge based expansion on heart valve disease and surgical heart valve therapies. Edwards Lifesciences will consider funding requests for programs that contain content and curricula that is relevant to structural heart disease, heart valve disease, and related topics, in alignment with Edwards Lifesciences’ stated training and educational objectives.

    Educational Objectives

    If your event or program is intended for the cardiothoracic surgeon or the heart team audience, then Edwards Lifesciences will consider providing grant funding support to educational topics that will:

    • Enhance understanding of newly released data relating to surgical valve interventions
    • Assist with understanding best practices to optimize the diagnosis of mitral and aortic valve disease, including aortic stenosis
    • Assist with heart valve procedure planning

    If your event or program is intended for the referring healthcare professional audience, then Edwards Lifesciences will carefully consider the request against the educational objectives cited above.

    Important safety information

    INSPIRIS RESILIA aortic valve

    Indications: For use in replacement of native or prosthetic aortic heart valves.

    Important safety information

    INSPIRIS RESILIA aortic valve

    Indications: For use in replacement of native or prosthetic aortic heart valves.

    Contraindications: There are no known contraindications with the use of the INSPIRIS RESILIA aortic valve.

    Complications and Side Effects:Thromboembolism, valve thrombosis, hemorrhage, hemolysis, regurgitation, endocarditis, structural valve deterioration, nonstructural dysfunction, stenosis, arrhythmia, transient ischemic attack/stroke, congestive heart failure, myocardial infarction, any of which could lead to reoperation, explantation, permanent disability, and death.

    Warnings: DO NOT ADJUST THE VALVE DIAMETER BY EXPANDING THE BAND PRIOR TO/OR DURING IMPLANTATION OF THE SURGICAL VALVE. The expandable band is not designed to allow for compression or expansion during implantation of the surgical valve. This will cause damage to the valve and may result in aortic incompetence. DO NOT PERFORM STAND-ALONE BALLOON AORTIC VALVULOPLASTY PROCEDURES ON THIS VALVE FOR THE SIZES 19 – 25 mm as this may expand the valve causing aortic incompetence, coronary embolism or annular rupture. Valve-in-valve sizing in the INSPIRIS valve has only been tested with specific Edwards transcatheter heart valves. Use of other transcatheter valves may result in embolization of transcatheter devices anchored within or result in annular rupture.

    Caution: Federal (United States) law restricts this device to sale by or on the order of a physician.See instructions for use for full prescribing information.

    © Edwards Lifesciences Corporation. All rights reserved.